For those affected by wildfires in Washington
If you or someone you know is affected by wildfires in Washington state, visit our wildfire response page for the latest information, resources, and updates.
Meetings and materials
The P&T Committee / DUR Board meet at least quarterly. All meetings are open to the public.
Seeking applications for P&T committee members
The Washington State Health Care Authority is seeking applications from interested physicians to fill an opening on the Washington State Pharmacy & Therapeutics (P&T) Committee beginning on August 1, 2026. The initial term of appointment is 3 years. Members of the committee are expected to attend four full day virtual meetings a year, with a few hours of reading to prepare for the meeting. Members of the committee will be compensated for attendance at meetings in accordance with a personal services contract executed after appointment to the committee. View the solicitation letter for more information.
On this page
Meetings and materials: Pharmacy and Therapeutic (P&T) Committee/Drug Utilization Review (DUR) Board
2026 meeting schedule
- February 18
- April 15
- August 19
- October 21
Materials
Drug class reports will be taken down 30 days after the meeting.
| Date | General documents | P&T Documents | DUR documents |
|---|---|---|---|
|
August 19, 2026 9 a.m. - 4 p.m. |
|||
|
April 15, 2026 |
|
||
|
February 18, 2026 |
Meeting details
- All P&T Committee/DUR Board meetings are open to the public.
- Stakeholders will be allowed three minutes for comments.
- Written testimony: If you would like to give testimony, but cannot attend a meeting, please email a two-page maximum letter to the WPDP program at least one week before the meeting. If you provide new drug information that has not been reviewed by the Drug Effectiveness Review Project (DERP), it cannot be considered by the committee.
- Committee discussion and motions follow stakeholder comments.
- For Apple Health PDL or drug policy questions email Apple Health Pharmacy Policy.
- Meetings are sponsored by the Health Care Authority and meet requirements of the Americans with Disabilities Act. Please call our ADA Coordinator at 360-725-9976 to make a request for special accommodations. TRS users may call this number through the Washington Relay Service by dialing 711.
Meetings held by webinar
If you would like to speak on any topic listed on the agenda, email the WPDP program, by the Friday before the meeting date:
- Your name;
- The organization you represent;
- The drug class name on the agenda;
- The completed Stakeholder Conflict of Interest Form.
The Committee Chair will call these names after the drug class presentation. You will be unmuted and have 3 minutes to speak. If you do not sign up ahead of time, but would like to speak at the meeting, the Committee Chair will ask if there are any other stakeholders. "Raise your hand", you will be unmuted when your name is called. You will have 3 minutes to speak. You can also ask questions in the "chat" box.
Meetings held at HCA
- View directions to HCA's Cherry Street Plaza
- Stakeholder sign-up sheets for testimony or comment will be available in the lobby.
Medicaid supplemental rebates
Effective January 1, 2018 HCA joined The Optimal PDL Solution (TOP$) supplemental rebate pool administered by Provider Synergies, LLC is a subsidiary of Prime Therapeutics State Government Solutions, LLC.
Please refer to the TOP$ website for more information about contracting and submitting rebates.
Request archived materials
To request archived materials, email the Prescription Drug Program.
Stakeholder list
If you would like to receive P&T/DUR meeting agendas and drug class updates sign up for the Prescription Drug Program Stakeholder List.